| Literature DB >> 35959406 |
Fei Peng1, Lang Liu2, Hao Niu1, Xin Feng3, Hong Zhang4, Xiaoxin He1, Jiaxiang Xia1, Boya Xu1, Xiaoyan Bai5, Zhiye Li5, Binbin Sui6, Aihua Liu1,2.
Abstract
Background: To investigate the quantification of aneurysmal wall enhancement (AWE) in fusiform intracranial aneurysms (FIAs) and to compare AWE parameters based on different sections of FIAs in identifying aneurysm symptoms.Entities:
Keywords: MRI; aneurysm wall enhancement; fusiform aneurysm; quantification; symptom
Year: 2022 PMID: 35959406 PMCID: PMC9361002 DOI: 10.3389/fneur.2022.945526
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Figure 1Three types of FIAs: fusiform (A), dolichoectatic (B), and transitional (C). Time-of-flight MR images (left column), post-contrast high-resolution MR images in the long-axis of the FIAs (middle column), and post-contrast high-resolution MR images in the cross-section of the FIAs (right column) are illustrated by each IFA (star).
Figure 2Flowchart of patients' selection.
Characteristics of patients and IFAs.
|
| |
|---|---|
| Age, mean ± SD | 52.05 ± 10.28 |
| Male, | 34 (79.1) |
| Hypertension, | 22 (51.2) |
| Hyperlipidemia, | 14 (32.6) |
| Diabetes, | 8 (18.6) |
| Current smoker, | 8 (58.1) |
| Location, | |
| ICA | 2 (4.7) |
| BA | 20 (46.5) |
| VA | 8 (18.6) |
| VB | 13 (30.2) |
| Type of IFAs, | |
| Fusiform | 30 (69.7) |
| Dolichoectatic | 6 (14.0) |
| Transitional | 7 (16.3) |
| 9.07 ± 2.58 | |
| 17.72 ± 9.50 | |
| Aneurysm symptoms, | |
| Sentinel headache | 13 (30.2) |
| Oculomotor nerve palsy | 5 (11.6) |
| CRstalk−cross, mean ± SD | 0.88 ± 0.26 |
| CRstalk−long, mean ± SD | 0.72 ± 0.21 |
ICA, internal carotid artery; BA, basilar artery; VA, vertebral artery; VB, vertebral basilar artery; IFAs, intracranial fusiform aneurysms; AWE, aneurysmal wall enhancement; CR.
The association between patients' and aneurysmal characteristics and aneurysm symptoms.
|
|
|
|
|
|---|---|---|---|
| Male sex, | 12 (27.9) | 22 (51.2) | 0.133 |
| Age, mean ± SD | 54.72 ± 10.09 | 48.33 ± 9.62 | 0.013 |
| Hypertension | 7 (16.3) | 15 (34.9) | 0.223 |
| Hyperlipidemia | 7 (16.3) | 7 (16.3) | 0.521 |
| Smoking history | 10 (23.3) | 15 (34.9) | 1.000 |
| Aneurysm location | 0.646 | ||
| ICA | 0 (0) | 2 (4.7) | |
| BA | 9 (20.9) | 11 (25.6) | |
| VA | 8 (18.6) | 10 (23.3) | |
| VB | 1 (2.3) | 2 (4.7) | |
| IFAs type | 0.167 | ||
| Fusiform, | 10 (23.3) | 20 (46.5) | |
| Dolichoectatic, | 3 (7.0) | 3 (7.0) | |
| Transitional, | 5 (11.6) | 2 (4.7) | |
|
| 13.25 ± 2.89 | 8.47 ± 2.79 | 0.563 |
|
| 20.65 ± 11.12 | 9.47 ± 2.39 | 0.066 |
| Mural thrombus, | 11 (25.6) | 9 (20.9) | 0.130 |
| CRstalk−cross | 0.96 ± 0.22 | 0.75 ± 0.28 | 0.027 |
| CRstalk−long | 0.79 ± 0.18 | 0.67 ± 0.21 | 0.055 |
ICA, internal carotid artery; BA, basilar artery; VA, vertebral artery; VB, vertebral basilar artery; FIA, fusiform intracranial aneurysms; CR.
P < 0.05.
Three models of multivariate logistic regression analysis for risk factors associated with aneurysmal symptoms.
|
|
|
|
|
|
|---|---|---|---|---|
| Cross-section model | Male | 7.352 | 1.113–48.548 | 0.038 |
| Age | 0.914 | 0.848–0.984 | 0.018 | |
| Mural thrombus | 2.911 | 0.559–15.161 | 0.204 | |
| IFAs type | 2.558 | 0.900–7.271 | 0.078 | |
| CRstalk−cross | 2.346 | 1.006–5.472 | 0.048 | |
| Long-axis section model | Male | 7.932 | 1.100–57.218 | 0.040 |
| Age | 0.900 | 0.830–0.975 | 0.010 | |
| Mural thrombus | 1.821 | 0.286–11.604 | 0.526 | |
| IFAs type | 1.527 | 0.416–5.607 | 0.524 | |
| CRstalk−long | 2.536 | 1.018–6.323 | 0.046 | |
|
| 1.138 | 1.021–1.269 | 0.019 | |
| Combination model | Male | 9.631 | 1.298–71.437 | 0.027 |
| Age | 0.900 | 0.830–0.976 | 0.011 | |
| IFAs type | 1.544 | 0.426–5.598 | 0.509 | |
| Mural thrombus | 1.312 | 0.191–9.002 | 0.783 | |
| CRstalk−cross, per SD | 2.995 | 1.115–8.042 | 0.030 | |
| CRstalk−long, per SD | 1.054 | 0.206–5.396 | 0.949 | |
|
| 1.136 | 1.020–1.264 | 0.020 |
CR.
P < 0.05.
Figure 3ROC curves of the contrast ratio of CRstalk−cross, Lmax, and the joint variable (CRstalk−cross + Lmax). The AUC value of CRstalk−cross, Lmax, and CRstalk−cross + Lmax were 0.701, 0.666, and 0.780, respectively. CRstalk−cross, aneurysm-to-pituitary stalk in the cross-axis section; Lmax, the maximal length of the long-axis section.